Monogram Orthopaedics Inc...

NASDAQ: MGRM · Real-Time Price · USD
5.36
0.01 (0.19%)
At close: Aug 15, 2025, 12:13 PM

Monogram Orthopaedics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a 365K 365K 365K 365K n/a n/a n/a n/a 1.8K 3.6K 317.72K 631.85K 630.05K 628.25K 314.12K
Cost of Revenue
n/a n/a 105.04K 105.04K 105.04K 105.04K n/a n/a n/a n/a 900.00 1.8K 232.04K 462.27K 461.38K 460.48K 230.24K
Gross Profit
-106.85K -212.74K 47.21K -55.89K -50.73K -47.34K -307.29K -204.19K -102.5K -96.64K -95.74K -94.84K -10.96K 169.57K 168.67K 167.77K 83.89K
Operating Income
-15.03M -15.31M -16.27M -14.88M -16.98M -17.27M -16.59M -14.65M -10.74M -10.61M -10.1M -10.98M -11.6M -10.28M -8.79M -7.29M -7.07M
Interest Income
568.54K 526K 534.58K 536.93K 502.57K 433.94K 245.38K 164.43K 127.29K 98.06K 79.53K 60.84K 38.56K 35.25K 74.65K 114.05K 127.86K
Pretax Income
-16.01M -16.33M -15.73M -11.69M -13.39M -13.75M -13.2M -16.42M -13.05M -13.69M -13.91M -13.03M -13.74M -11.81M -10.41M -9.01M -9.04M
Net Income
-16.01M -16.33M -15.73M -11.69M -13.39M -13.75M -13.2M -16.42M -13.05M -13.69M -13.91M -13.03M -13.74M -11.81M -10.41M -9.01M -9.04M
Selling & General & Admin
6.39M 6.52M 5.95M 4.11M 5.67M 6.42M 6.94M 6.49M 4.38M 5.23M 5.38M 6.02M 6.67M 5.17M 4.2M 3.24M 2.71M
Research & Development
8.64M 8.79M 10.68M 10.92M 11.23M 10.54M 8.56M 7.28M 5.85M 5.09M 4.84M 5.08M 5.01M 5.28M 4.75M 4.22M 4.45M
Other Expenses
n/a n/a -339 -339 n/a n/a 339.00 339.00 8.00 8.00 8.00 8.00 n/a n/a n/a n/a n/a
Operating Expenses
15.03M 15.2M 16.42M 15.03M 17.14M 17.53M 16.59M 14.65M 10.74M 10.61M 10.1M 10.97M 11.68M 10.44M 9.74M 9.04M 9.09M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
2.03M 2.11M 2.21M 406.54K 1.99M 3M 3.18M 3.25M 1.64M 2.71M 3.32M 4.17M 4.79M 3.27M 2.46M 1.64M 1.43M
Cost & Expenses
15.03M 15.31M 16.63M 15.24M 17.35M 17.63M 16.33M 14.39M 10.48M 10.36M 10.76M 12.3M 13.36M 12.47M 11.11M 9.74M 9.44M
Income Tax Expense
n/a n/a n/a n/a n/a -37.34K -37.34K -37.34K -7.62K 29.72K 29.72K 29.72K n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
35.21M 32.57M 32.22M 31.56M 31.54M 31.34M 29.3M 19.27M 29.25M 9.67M 30.92M 30.92M 29.25M 9.67M 9.67M 9.67M 9.67M
Shares Outstanding (Diluted)
35.21M 32.57M 32.22M 31.56M 31.54M 31.34M 29.3M 19.27M 29.25M 9.67M 30.92M 30.92M 29.25M 9.67M 9.67M 9.67M 9.67M
EPS (Basic)
-0.5 -0.51 -0.5 -0.37 -0.53 -0.55 -0.75 -0.86 -0.65 -0.67 -0.69 -0.89 -1.1 -1.22 -1.08 -0.94 -0.96
EPS (Diluted)
-0.5 -0.51 -0.5 -0.37 -0.53 -0.55 -0.75 -0.86 -0.65 -0.67 -0.69 -0.89 -1.1 -1.22 -1.08 -0.94 -0.96
EBITDA
-14.6M -14.88M -15.84M -14.46M -16.57M -16.85M -15.93M -13.99M -10.09M -9.97M -9.72M -10.6M -11.24M -9.96M -8.52M -7.08M -6.92M
EBIT
-15.03M -15.31M -16.27M -14.88M -16.98M -17.27M -16.33M -14.39M -10.48M -10.36M -10.1M -10.98M -11.6M -10.28M -8.79M -7.29M -7.07M
Depreciation & Amortization
432.1K 430K 426.16K 420.89K 415.73K 412.33K 407.97K 402.54K 392.55K 386.69K 380.95K 378.21K 352.57K 321.98K 267.07K 212.16K 153.93K